New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2014
08:12 EDTILMNIllumina price target raised to $160 from $140 at Leerink
Leerink raised its price target for Illumina shares to $160 citing the company's solid Q4 results and keeps an Outperform rating on the stock.
News For ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
18:51 EDTILMNOn The Fly: After Hours Movers
Subscribe for More Information
16:51 EDTILMNIllumina up 9.8% after reporting Q3 results
Subscribe for More Information
16:13 EDTILMNIllumina trades higher after results, first look
Subscribe for More Information
16:11 EDTILMNIllumina raises FY14 EPS view to $2.63-$2.65, consensus $2.30
Raises FY14 revenue growth view to approximately 30% YoY, consensus $1.8B. Prior view was $2.26-$2.28 for EPS and 25%-26% for revenue growth. Cites strong year to date results.
16:09 EDTILMNIllumina reports Q3 gross margin 69.5% vs. 58.8% in prior year period
Subscribe for More Information
16:09 EDTILMNIllumina reports Q3 adjusted EPS 77c, consensus 56c
Subscribe for More Information
15:30 EDTILMNNotable companies reporting after market close
Subscribe for More Information
07:11 EDTILMNAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
07:10 EDTILMNAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 16, 2014
10:01 EDTILMNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:33 EDTILMNIllumina upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
October 15, 2014
06:32 EDTILMNIllumina to invest in three genomics industry startups
Illumina selected three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics, EpiBiome and Xcell Biosciences. The Illumina Accelerator will provide selected startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during the six-month cycle.
October 14, 2014
08:15 EDTILMNIllumina should report stronger than expected results, says Wedbush
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use